Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00745550Phase 1/2Completed
A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis
Essential ThrombocythemiaMyelofibrosisMyeloproliferative Disorders+1 more
Principalinvestigator

Research Network

Collaboration Network

21 collaborators·30 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peter MacCallum Cancer Centre, Australia

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Bik To, MD

Royal Adelaide Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPrimary MyelofibrosisMyeloproliferative Disorders+1 more

Worked with same sponsors:

S*BIO
Collaborated on 1 trial
Similarity Score44%

Rami Komrokji, MD

H. Lee Moffitt Cancer Center and Research Institute

Moderately Similar
5 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPrimary MyelofibrosisMyeloproliferative Disorders+1 more

Worked with same sponsors:

S*BIO
Collaborated on 1 trial
Similarity Score44%

Martha Wadleigh, MD

Dana-Farber Cancer Institute

Moderately Similar
3 trials

Shared therapeutic areas:

Primary MyelofibrosisThrombocythemia, EssentialMyeloproliferative Disorders+1 more

Worked with same sponsors:

S*BIO
Collaborated on 1 trial
Similarity Score44%

Andrew Roberts, M.D.

Melbourne Health

Moderately Similar
1 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPrimary MyelofibrosisMyeloproliferative Disorders+1 more

Worked with same sponsors:

S*BIO
Collaborated on 1 trial
Similarity Score44%

Ruben Mesa, MD

Mayo Clinic

Moderately Similar
2 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPrimary MyelofibrosisMyeloproliferative Disorders+1 more

Worked with same sponsors:

S*BIO
Collaborated on 1 trial
Similarity Score44%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Primary MyelofibrosisThrombocythemia, EssentialPolycythemia Vera
Similarity Score23%

John Mascarenhas, MD

Icahn School of Medicine at Mount Sinai

Related
16 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia VeraThrombocythemia, Essential
Similarity Score23%

Ronald Hoffman, MD

Icahn School of Medicine at Mount Sinai

Related
10 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia VeraThrombocythemia, Essential
Similarity Score23%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPolycythemia VeraPrimary Myelofibrosis
Similarity Score23%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Primary MyelofibrosisMyeloproliferative Disorders
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00745550Phase 1/2PrincipalInvestigator

A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis

Essential ThrombocythemiaMyelofibrosisMyeloproliferative Disorders+1 more
Completed

All 1 trials loaded